Michitaka Akima

971 total citations
67 papers, 847 citations indexed

About

Michitaka Akima is a scholar working on Physiology, Pathology and Forensic Medicine and Molecular Biology. According to data from OpenAlex, Michitaka Akima has authored 67 papers receiving a total of 847 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Physiology, 19 papers in Pathology and Forensic Medicine and 14 papers in Molecular Biology. Recurrent topics in Michitaka Akima's work include Nitric Oxide and Endothelin Effects (20 papers), Cardiac Ischemia and Reperfusion (19 papers) and Cardiac electrophysiology and arrhythmias (10 papers). Michitaka Akima is often cited by papers focused on Nitric Oxide and Endothelin Effects (20 papers), Cardiac Ischemia and Reperfusion (19 papers) and Cardiac electrophysiology and arrhythmias (10 papers). Michitaka Akima collaborates with scholars based in United States, Japan and United Kingdom. Michitaka Akima's co-authors include Kazushige Sakai, N. OHI, Yoshiyuki Suzuki, Kazuhiko Tamura, Tatsuya Kato, Toshio Kuroki, Hiroyuki Nabata, Keiji Saito, Hisanori Takanashi and Yasuhiro Ohba and has published in prestigious journals such as Gastroenterology, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Michitaka Akima

66 papers receiving 751 citations

Peers

Countries citing papers authored by Michitaka Akima

Since Specialization

Citations

This map shows the geographic impact of Michitaka Akima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michitaka Akima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michitaka Akima more than expected).

Fields of papers citing papers by Michitaka Akima

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michitaka Akima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michitaka Akima. The network helps show where Michitaka Akima may publish in the future.

Co-authorship network of co-authors of Michitaka Akima

This figure shows the co-authorship network connecting the top 25 collaborators of Michitaka Akima. A scholar is included among the top collaborators of Michitaka Akima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michitaka Akima. Michitaka Akima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Effects of Mitemcinal (GM-611), an Acid-Resistant Nonpeptide Motilin Receptor Agonist, on the Gastrointestinal Contractile Activity in Conscious Dogs 2007 ·Pharmacology ·Kenichi Ozaki, Kenji Yogo, (unknown), (unknown), (unknown), Michitaka Akima, Hiroshi Koga, Zen Itoh, Satoshi Ōmura, Hisanori Takanashi	21
2	Effects of CP‐060S, a novel cardioprotective drug, in the methacholine‐induced ECG change model in rats 2001 ·Fundamental and Clinical Pharmacology ·Masanori Fukazawa, Yuichiro Adachi, Michitaka Akima, Jun‐ichi Imagawa, Yoshiyuki Suzuki, (unknown), Kazuhiko Tamura	3
3	Nicorandil Metabolism in Rat Myocardial Mitochondria 2000 ·Journal of Cardiovascular Pharmacology ·Kazushige Sakai, Michitaka Akima, Keiji Saito, (unknown), Shuzo Matsubara	20
4	Effects of CP-060S, a Novel Cardioprotective Drug, on Cardiac Function and Myocardial Oxygen Consumption 1999 ·General Pharmacology The Vascular System ·Yoshiyuki Suzuki, Michitaka Akima, Kazuhiko Tamura	12
5	The protective effects of CP‐060S on ischaemia‐ and reperfusion‐induced arrhythmias in anaesthetized rats 1998 ·British Journal of Pharmacology ·(unknown), Masanori Fukazawa, Yoshiyuki Suzuki, Michitaka Akima, Yuichiro Adachi, Kazuhiko Tamura, Tatsuya Kato, (unknown)	14
6	Vascular Levels and cGMP-Increasing Effects of Nicorandil Administered Orally to Rats 1998 ·Journal of Cardiovascular Pharmacology ·Kazushige Sakai, (unknown), (unknown), Michitaka Akima, Shinichi Kamachi, (unknown)	7
7	CP-060S, a Novel Cardioprotective Drug, Limits Myocardial Infarct Size in Anesthetized Dogs 1998 ·Journal of Cardiovascular Pharmacology ·Yoshiyuki Suzuki, Kazuhiko Tamura, Michitaka Akima, Yuichiro Adachi, Masanori Fukazawa, Tatsuya Kato	11
8	Role for adenosine A1 and A2 receptors in femoral vasodilatation induced by intra-arterial adenosine in rabbits 1998 ·European Journal of Pharmacology ·Kazushige Sakai, (unknown), Michitaka Akima, Keiji Saito	6
9	GM-109: a novel, selective motilin receptor antagonist in the smooth muscle of the rabbit small intestine. 1995 ·Journal of Pharmacology and Experimental Therapeutics ·Hisanori Takanashi, Kenji Yogo, Kenichi Ozaki, (unknown), Michitaka Akima, Hiroshi Koga, Hiroyuki Nabata	40
10	Novel Antiasthmatic Agents with Dual Activities of Thromboxane A2 Synthetase Inhibition and Bronchodilation. VI. Indazole Derivatives. 1995 ·Chemical and Pharmaceutical Bulletin ·Masashi Yamaguchi, (unknown), (unknown), Koji Kamei, Michitaka Akima, Toshio Kuroki, Masatomo Hamana, Naoto Ohi	14
11	Novel Antiasthmatic Agents with Dual Activities of Thromboxane A2 Synthetase Inhibition and Bronchodilation. V. Thienopyridazinone Derivatives. 1995 ·Chemical and Pharmaceutical Bulletin ·Masashi Yamaguchi, (unknown), (unknown), Koji Kamei, Michitaka Akima, Toshio Kuroki, Masatomo Hamana, Naoto Ohi	34
12	Novel Antiasthmatic Agents with Dual Activities of Thromboxane A2 Synthetase Inhibition and Bronchodilation. III. 4-(2-(5-Ethyl-2-thienyl))-2'-(2-(1-imidazolyl)ethyl)-1(2H)-phthalazinones. 1994 ·Chemical and Pharmaceutical Bulletin ·Masashi Yamaguchi, (unknown), Koji Kamei, Michitaka Akima, Toshio Kuroki, Masatomo Hamana, Naoto Ohi	3
13	Novel Antiasthmatic Agents with Dual Activities of Thromboxane A2 Synthetase Inhibition and Bronchodilation. IV. 2-(2-(1-Imidazolyl)ethyl)-4-(3-pyridyl)-1(2H)-phthalazinones. 1994 ·Chemical and Pharmaceutical Bulletin ·Masashi Yamaguchi, (unknown), Kaeko Kamei, Michitaka Akima, (unknown), Toshio Kuroki, Masatomo Hamana, Naoto Ohi	14
14	Novel antiasthmatic agents with dual activities of thromboxane A2 synthetase inhibition and bronchodilation. 2. 4-(3-Pyridyl)-1(2H)-phthalazinones 1993 ·Journal of Medicinal Chemistry ·(unknown), (unknown), (unknown), Michitaka Akima, (unknown), Toshio Kuroki, N. OHI	23
15	Comparative studies with 15(R)-15-methylprostaglandin E2 (arbaprostil) in rat femoral arterial preparations in vivo and in vitro 1993 ·General Pharmacology The Vascular System ·Hisanori Takanashi, Kenji Yogo, (unknown), Michitaka Akima	1
16	Novel antiasthmatic agents with dual activities of thromboxane A2 synthetase inhibition and bronchodilation. 1. 2-[2-(1-Imidazolyl)alkyl]-1(2H)-phthalazinones 1993 ·Journal of Medicinal Chemistry ·(unknown), (unknown), (unknown), Michitaka Akima, Toshio Kuroki, N. OHI	83
17	Effects of Cisapride on Gastrointestinal Motor Activity and Gastric Emptying of Disopyramide. 1992 ·Journal of Pharmacobio-Dynamics ·T. Kuroda, (unknown), (unknown), (unknown), (unknown), Hisashi Fukuzaki, Hisanori Takanashi, Kenji Yogo, Michitaka Akima	6
18	Acid-Promoted Epimerization of Arbaprostil, 15(R)-15-Methylprostaglandin E2, Elicits Gastric Antisecretory Activities in Rats. 1991 ·The Japanese Journal of Pharmacology ·Hisanori Takanashi, Yoshiki Kawabe, Michitaka Akima	2
19	Hematoma in the pineal region: A case report 1985 ·(unknown), Ken-ichi Sugiura, (unknown), (unknown), (unknown), (unknown), (unknown), Michitaka Akima	2
20	Effects of a new antianginal agent, nicorandil, on the cardiovascular system of the miniature pig: with special reference to coronary vasospasm. 1983 ·Journal of Pharmacology and Experimental Therapeutics ·Kazushige Sakai, Michitaka Akima, (unknown), E. Hoshino	18

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact